UTILITY OF IMMUNOPHENOTYPIC STUDIES IN THE DIAGNOSIS OF LOW-GRADE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT) AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS OF EXTRANODAL SITES
Dm. Dorfman et Gs. Pinkus, UTILITY OF IMMUNOPHENOTYPIC STUDIES IN THE DIAGNOSIS OF LOW-GRADE LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE (MALT) AND OTHER LOW-GRADE NON-HODGKINS-LYMPHOMAS OF EXTRANODAL SITES, Applied immunohistochemistry, 3(3), 1995, pp. 160-167
The diagnosis of extranodal low-grade B-cell neoplasms may pose a diff
icult problem, particularly in limited tissue samples. This study comp
ares the immunohistochemical staining patterns of extranodal low-grade
B-cell lymphoproliferative disorders, including low-grade lymphoma of
mucosa-associated lymphoid tissue (MALT lymphoma; 26 cases), small ly
mphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL; five cases),
and mantle cell lymphoma (MCL; six cases) to determine whether charac
teristic immunophenotypic patterns of these disorders would be apparen
t at various extranodal sites and whether immunohistochemical markers,
including CDS, CD23, and CD43, could aid in discriminating among them
. All cases were immunoreactive for pan-B-cell markers (CD19, CD20, CD
22), exhibited monotypic immunoglobulin light chain staining, and were
nonreactive for CD10 (CALLA). These B-cell disorders were generally a
lso immunoreactive for CD43. Although the latter preferential T-cell m
arker could not be used to discriminate among these lesions, its prese
nce supported the diagnosis of a B-cell neoplasm. However, the immunoh
istochemical markers CD5 and CD23 were useful in establishing the spec
ific diagnoses of MALT lymphoma [generally, CD5 (-), CD23 (-)], SLL/CL
L [generally, CD5 (+), CD23 (+)], and MCL [generally CD5 (+), CD23 (-)
] at extranodal sites and in discriminating among these entities in a
statistically significant fashion, even in limited biopsy specimens.